C. difficile is a bacterium that causes diarrhea and sometimes can lead to serious intestinal conditions or complications.

VLA84 – Valneva’s Clostridium difficile vaccine candidate that remains on hold

  • Valneva has developed VLA84, a vaccine candidate against Clostridium difficile, a leading cause of life threatening, healthcare associated infections worldwide.
  • Valneva completed Phase 2 development of VLA84 and could advance into Phase 3 if it chooses to reactivate this program and find a suitable partner.


Additional information about Clostridium difficile: